Disease | Type | Disease Class | Semantic Type | N. genes d | N. SNPs d | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
disease | Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | Neoplastic Process | 295 | 11 | 0.300 | None | 1.000 | 1 | 2017 | 2017 | |||||
|
disease | Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | Neoplastic Process | 664 | 22 | 0.300 | None | 1.000 | 1 | 2017 | 2017 | |||||
|
phenotype | Organism Attribute | 1903 | 3972 | 0.100 | None | 1.000 | 9 | 12 | 2008 | 2019 | |||||
|
phenotype | Laboratory Procedure | 223 | 371 | 0.100 | None | 1.000 | 5 | 5 | 2009 | 2016 | |||||
|
phenotype | Organism Attribute | 565 | 1138 | 0.100 | None | 1.000 | 5 | 5 | 2010 | 2019 | |||||
|
phenotype | Organism Attribute | 249 | 517 | 0.100 | None | 1.000 | 3 | 4 | 2008 | 2013 | |||||
|
phenotype | Laboratory Procedure | 265 | 457 | 0.100 | None | 1.000 | 3 | 5 | 2011 | 2018 | |||||
|
phenotype | Laboratory Procedure | 563 | 1418 | 0.100 | None | 1.000 | 2 | 2 | 2017 | 2018 | |||||
|
phenotype | Clinical Attribute | 843 | 1931 | 0.100 | None | 1.000 | 2 | 2 | 2017 | 2019 | |||||
|
phenotype | Laboratory Procedure | 545 | 1440 | 0.100 | None | 1.000 | 2 | 2 | 2017 | 2018 | |||||
|
phenotype | Clinical Attribute | 507 | 1037 | 0.100 | None | 1.000 | 2 | 1 | 2017 | 2017 | |||||
|
phenotype | Behavior and Behavior Mechanisms | Individual Behavior | 249 | 742 | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||
|
phenotype | Diagnostic Procedure | 54 | 314 | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||
|
phenotype | Clinical Attribute | 75 | 226 | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||
|
phenotype | Laboratory Procedure | 131 | 224 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
phenotype | Laboratory Procedure | 433 | 3282 | 0.100 | None | 1.000 | 1 | 3 | 2013 | 2013 | |||||
|
phenotype | Laboratory Procedure | 160 | 355 | 0.100 | None | 1.000 | 1 | 2 | 2017 | 2017 | |||||
|
disease | Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | Neoplastic Process | 2542 | 757 | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||
|
disease | Neoplastic Process | 41 | 103 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
phenotype | Laboratory Procedure | 134 | 200 | 0.100 | None | 1.000 | 1 | 3 | 2016 | 2016 | |||||
|
group | Neoplasms | Neoplastic Process | 569 | 154 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||
|
phenotype | Behavior and Behavior Mechanisms | Individual Behavior | 391 | 765 | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||
|
phenotype | Clinical Attribute | 138 | 654 | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 | |||||
|
phenotype | Diagnostic Procedure | 399 | 1033 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
phenotype | Laboratory Procedure | 717 | 1599 | 0.100 | None | 1.000 | 1 | 2 | 2019 | 2019 |